Simplifications in analyzing positron emission tomography data: effects on outcome measures

Nuclear Medicine and Biology

Volumn 34, Issue 7, 2007, Pages 743-756

  Logan, Jean ^a   Alexoff, David ^a   Kriplani, Aarti ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

IIC raclopride; FDG; PET; tracer kinetic modeling

Indexed keywords

ATOMOXETINE; CARBON 11; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; METHYLPHENIDATE; NORADRENALIN TRANSPORTER; O METHYLREBOXETINE C 11; PLACEBO; RACLOPRIDE C 11; REBOXETINE; TRACER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AREA UNDER THE CURVE; BLOOD SAMPLING; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG UPTAKE; GLUCOSE METABOLISM; HUMAN; MATHEMATICAL MODEL; NONHUMAN; PHARMACOKINETICS; PLASMA PROTEIN BINDING; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; REVIEW;

COMPUTER SIMULATION; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPE DILUTION TECHNIQUE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34848883382     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.06.003     Document Type: Review

References (52)

1. Logan J., Fowler J., Volkow N., Wang G., Ding Y., and Alexoff D. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16 (1996) 834-840
2. Ichise M., and Ballinger J. From graphical analysis to multilinear regression analysis of reversible radioligand binding. J Cereb Blood Flow Metab 16 (1996) 750-752
3. Lammertsma A., and Hume S. Simplified reference tissue model for PET receptor studies. Neuroimage 4 (1996) 153-158
4. Ichise M., Ballinger J.R., Golan H., Vines D., Luong A., Tsai S., et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med 37 (1996) 513-520
5. Ichise M., Toyama H., Innis R., and Carson R. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 22 (2002) 1271-1281
6. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23 (2003) 1096-1112
7. Feng D., Wong K., Wu C., and Siu W. A technique for extracting physiological parameters and the required input function simultaneously from PET image measurements: theory and simulation study. IEEE Trans Inf Technol Biomed 1 (1997) 243-254
8. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 46 (2005) 1959-1972
9. Patlak C., and Blasberg R. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5 (1985) 584-590
10. 11C]raclopride studies. J Cereb Blood Flow Metab 16 (1996) 42-52
11. Huang S. Anatomy of SUV: standardized uptake value. Nucl Med Biol 27 (2000) 643-646
12. Naganawa M., Kimura Y., Ishii K., Oda K., Ishiwata K., and Matani A. Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis. IEEE Trans Biomed Eng 52 (2005) 201-210
13. Naganawa M., Kimura Y., Nariai T., Ishii K., Oda K., Manabe Y., et al. Omission of serial arterial blood sampling in neuroreceptor imaging with independent component analysis. Neuroimage 26 (2005) 885-890
14. Cumming P., Yokoi F., Chen A., Deep P., Dagher A., Reutens D., et al. Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse 34 (1999) 124-134
15. Lo J., and Cumming J. Interaction between sedative premedicants and ketamine in man and in isolated perfused rat livers. Anesthesiology 43 (1975) 307-312
16. Ding Y., Lin K., Garza V., Carter P., Alexoff D., Logan J., et al. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse 50 (2003) 345-352
17. Ding Y., Lin K., and Logan J. PET imaging of norepinephrine transporters. Curr Pharm Des 12 (2006) 3831-3845
18. 11C]lortalamine. J Neurochem 94 (2005) 337-351
19. Volkow N.D., Wang G.-J., Telang F., Fowler J.S., Logan J., Ma Y., et al. Decreased dopaminergic responsiveness in alcoholic subjects. J Nucl Med 48 (2007) 100
20. 11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol (2007) 34
21. Volkow N.D., Wang G.-J., Telang F., Fowler J.S., Logan J., Childress A.-R., et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26 (2006) 6583-6588
22. Volkow N.D., Gur R.C., Wang G.-J., Fowler J.S., Moberg P.J., Ding Y.-S., et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155 (1998) 344-349
23. Gunn R., Lammertsma A., Hume S., and Cunningham V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6 (1997) 279-287
24. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27 (2000) 661-670
25. Aston-Jones G., Rajkowski J., Kubiak P., and Alexinsky T. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci 14 (1994) 4467-4480
26. Logan J., Ding Y., Lin K., Pareto D., Fowler J., and Biegon A. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. Nucl Med Biol 32 (2005) 531-542
27. Volkow N.D., Wang G.-J., Ma Y., Fowler J.S., Wong C., Ding Y.-S., et al. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci 25 (2005) 3932-3939
28. Wang G.-J., Yang J., Volkow N.D., Telang F., Ma Y., Zhu W., et al. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A 103 (2006) 15641-15645
29. 18F-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med 43 (2002) 1432-1437
30. Weber W., Bartenstein P., Gross M.W., Kinzel D., Daschner H., Feldmann H.J., et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 38 (1997) 802-808
31. Hawkins R.A., Choi Y., Huang S.-C., Messa C., Hoh C.K., and Phelps M.E. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 33 (1992) 339-344
32. 18F-FDG PET study on normal aging and Alzheimer's disease. J Nucl Med 45 (2004) 382-392
33. 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 42 (2001) 548-557
34. 18F-FDG PET measures in differentiating dementias. J Nucl Med 46 (2005) 936-944
35. 18F-FDG PET: a validation study. J Nucl Med 46 (2005) 1633-1641
36. 18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET). PNAS 98 (2001) 10966-10971
37. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28 (1977) 897-916
38. Huang S.C., Phelps M.E., Hoffman E.J., Sideris K., Selin C.J., and Kuhl D.E. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol Endocrinol Metab 238 (1980) E69-E82
39. Phelps M., Huang S., Hoffman E., Selin C., Sokoloff L., and Kuhl D. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol 6 (1979) 371-388
40. Eberl S., Anayat A., Fulton R., Hooper P., and Fulham M. Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur J Nucl Med 24 (1997) 299-304
41. Bentourkia M, Bol A, Michel C, Coppens A, Sibomana M, De Volder AG. A simplified blood sampling scheme in FDG-PET studies. Nuclear Science Symposium IEEE 1997;2:1711-5.
42. Wakita K., Imahori Y., Ido T., Fujii R., Horii H., Shimizu M., et al. Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method. J Nucl Med 41 (2000) 1484-1490
43. Bonson K.R., Grant S.J., Links J.M., and London E.D. Validation of an analytic method of calculating cerebral glucose metabolism using PET. J Nucl Med 41 (2000) 658-660
44. Bentourkia M. Kinetic modeling of PET_FDG in the brain without blood sampling. Computerized Medical Imaging and Graphics (wwwScienceDirectcom) 2006.
45. 11C]l-deprenyl in living baboon brain. J Neurochem 51 (1988) 1524-1534
46. Fowler J., Volkow N., Wang G., Pappas N., Shea C., MacGregor R., et al. Visualization of monoamine oxidase in human brain. Adv Pharmacol 42 (1998) 304-307
47. Fowler J., Logan J., Wang G., Volkow N., Telang F., Ding Y., et al. Comparison of the binding of the irreversible monoamine oxidase tracers, [(11)C]clorgyline and [(11)C]l-deprenyl in brain and peripheral organs in humans. Nucl Med Biol 31 (2004) 313-319
48. Fowler J., Logan J., Volkow N., Wang G., MacGregor R., and Ding Y. Monoamine oxidase: radiotracer development and human studies. Methods 27 (2002) 263-277
49. Fowler J., Logan J., Volkow N., and Wang G. Translational neuroimaging: positron emission tomography studies of monoamine oxidase. Mol Imaging Biol 7 (2005) 377-387
50. Kriplani A., Schlyer D., Logan J., and Fowler J. Consequences of partial volume effects and spillover in image derived input functions (2005)
51. Kriplani A, Stoll SP, Southekal S, Schlyer DJ, Park SJ, Villanueva A, et al. Noninvasive high-resolution detection of the arterial and venous input function through a PET wrist scanner. Nuclear Science Symposium Conference Record IEEE 2005:2240-4.
52. Kriplani A, Schlyer DJ, Vaska P, Stoll SP, Southekal S, Park SJ, et al. Non-Invasive and Selective Measurement of the Arterial Input Function Using a PET Wrist Scanner. Nuclear Science Symposium and Medical Imaging Conference Record 2006 IEEE 2006:3266-70.